The healthcare sector has been lackluster when it comes to its share of PE deals in 2013, according to Thomson Reuters data.
Check out 2013 vs. 2012 activity(Jan 1 - Sept 11):
2013: 268 deals valued at $5B
2012: 292 deals valued at $14.26B
A principal at The Riverside Company, Joseph Ibrahim, offers a differing perspective on this year's healthcare deal activity. That is, middle-market M&A activity has not experienced a significant decline. In fact, Ibrahim reveals "…[In terms of healthcare M&A], it was one of the strongest June, July and August [periods]."
Ibrahim's middle-market industry insight suggests there is a "backlog of deals that will come to market". Certainly, that activity would demonstrate continued strength in this healthcare segment. >>Read more
What triggered the overall healthcare PE deal slowdown in 2013? Was it Obamacare uncertainty, "hangover effect" from 2012, or...? Let us know your thoughts.
Source: PE Hub